Molecular Diagnostics Market Forecast 2013 - 2019

Embed Size (px)

DESCRIPTION

Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. Molecular diagnostics tests are considered as the most well established and lucrative market in the clinical applications segment. Traditionally, the usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of the global molecular diagnostics market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.

Text of Molecular Diagnostics Market Forecast 2013 - 2019

Transparency MarketResearch

Molecular Diagnostics Market -Global Industry Analysis, Size,

Share, Growth, Trends andForecast, 2013 - 2019

Single User License:USD 4595Multi User License:USD 7595Corporate User License: USD 10595

Molecular Diagnostics Market Expected to Reach USD 8.7 BillionGlobally in 2019: Transparency Market Research

Transparency Market Research State Tower,

90, State Street, Suite 700.Albany, NY 12207United Stateswww.transparencymarketresearch.comsales@transparencymarketresearch.com

122 Page ReportPublished Date23-May-2014

Buy Now Request Sample

Press Release

Molecular Diagnostics Market

According to a new market report published by Transparency Market Research "Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -2019," the global molecular diagnostics market was valued at USD 4.3 billion in 2012 and is expected to grow at a CAGR of 11.1 % from 2013 to 2019, to reach an estimated value of USD 8.7 billion in 2019.

Browse Molecular Diagnostics Market Report with Full TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html

Molecular diagnostics is defined as a class of diagnostic tests that identifies proteins or nucleic acid at a molecular level. This class of test assists in identification of genetic markers of patient or nucleic acids in foreign organism. Currently, molecular diagnostics forms relatively a small portion of the overall diagnostics market but is identified as the fastest growing sector. The growth of this segment is being supported by rapid turnaround time, low cost, convenient workflow and high sensitivity. Moreover, growth of this segment is fuelled by rising incidence of chronic disorders, increasing geriatric population and adoption of personalized medicines. Molecular diagnostics test is rapidly being developed for genetic testing, infectious diseases testing, blood screening, oncology testing, cardiovascular testing and others.

Molecular diagnostics is rapidly an evolving market supported by increasing R&D activities for biomarker identification coupled with emergence of new applications of these tests. Infectious disease alone captures60% share of the total molecular diagnostics applications market and remaining one third is attributed to genetic testing and blood donor screening. The growth of this segment is driven by rising incidence of cervical cancer caused due to Human Papilloma Virus (HPV). HPV is known to be a causative agent for cervical cancers hence HPV testing is projected to have a CAGR of 14.8% during the forecast period of 2013-2019. Hospital acquired infections (HAI)is anticipated as the fastest growing segment within infectious diseases and is expected to show CAGR of 15.1% from 2013-2019. Oncology testing and HLA typing testing are also projected to grow at a rapid rate during the same forecast period.

Technology wise, PCR accounts for the largest share followed by Transcription Mediated Amplification (TMA), with these two technologies accounting for nearly 50% of the share of molecular diagnostics market. Next generation sequencing is expected to witness the highest growth rate in the near future. High

Transparency Market Research2

REPORT DESCRIPTION

Ambulance Services Market

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

sensitivity, reliability and rapid turnaround time are some of the factors that are expected to trigger marketgrowth. Microarray and hybridization techniques are also expected to show moderate growth. However, issues with reimbursement policies and strict regulatory requirements are some factors, expected to hinder the growth of molecular diagnostics market.

Geographically, North America and Europe comprises majority of the molecular diagnostics market share. Increasing investments in genomics and proteomics, rising awareness and acceptance of personalized medicines along with increasing incidence of chronic diseases are some of the factors that have driven the molecular diagnostics industry in these regions. However, Asia-Pacific is projected to witness fastest growth rate during the forecast period, reporting a CAGR of more than 14%. Economic developments and rising patient awareness towards wellness, preventive medicine and access to technologically advanced products are some of the key growth factors in this region. Additionally, growth in this market is fuelled by spread of infectious diseases such as H1N1, HIV, rise in aging population, and robust government support.

Molecular diagnostics market is highly fragmented comprising small and large vendors. Roche Diagnostics is expected to lead the market owing to its extensive product portfolio in the molecular diagnostics segment. Other players of this market include Novartis Diagnostics, Abbott Laboratories, Qiagen, Hologic Gen-Probe, among others.Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Molecular DiagnosticsMarket, by Technology

- PCR

- Transcription mediated amplification (TMA)

- Next generation sequencing

- Microarray

- Hybridization techniques

- Others

Molecular DiagnosticsMarket, by Application

Transparency Market Research3

Ambulance Services Market

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Infectious diseases

Virology

- HIV testing

- HPV testing

- HCV testing

- Others

Bacteriology

- HAI testing

- CT/NG testing

- Others

Genomics

- Genetic Testing for Inherited Disorders

- Human Leukocyte Antigen (HLA) Testing

- Pharmacogenetics Testing

- Oncology Testing

- Blood Donor Screening

- Others

Molecular DiagnosticsMarket, by Geography

- North America

- Europe

Transparency Market Research4

Ambulance Services Market

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

- Asia-Pacific

- RoW

Browse Molecular Diagnostics Market Report with Full TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html

Table of Content

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.3.1 Assumptions

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)

2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)

Chapter 3 Market Overview

3.1 Overview

3.2 Market Drivers

Transparency Market Research5

TABLE OF CONTENT

Ambulance Services Market

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

3.2.1 Rising incidence of cancer cases

3.2.2 Aging population

3.2.3 Increase in incidence of chronic diseases

3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines

3.3 Market Restraints

3.3.1 Issues with reimbursement policies

3.4 Market Opportunities

3.4.1 Technological advancements

3.4.2 Tapping the emerging economies

3.5 Porters Five Force Analysis: Global Molecular Diagnostics Market

3.5.1 Bargaining Power of Suppliers

3.5.2 Bargaining Power of Buyers

3.5.3 Threat of New Entrants

3.5.4 Threat of Substitutes

3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography

Chapter 4 Molecular Diagnostics Market, by Technology

4.1 Overview

4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 2019 (USD Million)

Transparency Market Research6

Ambulance Services Market

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

4.2 Polymerase Chain Reaction (PCR)

4.2.1 Global PCR Market, 2011 2019 (USD Million)

4.3 Transcription Mediated Amplification (TMA)

4.3.1 Global TMA Market, 2011 2019 (USD Million)

4.4 Microarray

4.4.1 Global Microarray Market, 2011 2019 (USD Million)

4.5 Hybridization (ISH and FISH)

4.5.1 Global Hybridization Market, 2011 2019 (USD Million)

4.6 Next-generation sequencing

4.6.1 Global Next generation sequencing Market, 2011 2019 (USD Million)

4.7 Others

4.7.1 Global Others Market, 2011 2019 (USD Million)

Chapter 5 Global Molecular Diagnostics Market, by Applications

5.1 Overview

5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 2019 (USD Million)

5.2 Infectious Diseases

5.2.1 Global Infectious Diseases Market, by Segments, 2011 2019 (USD Million)

5.2.2 Virology

5.2.2.1 Global Virology Market, by Segments, 2011 2019 (USD Million)

Transparency Market Research7

Ambulance Services Market

Browse all Medical Devices Market Research Reports @ http: